These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 33485248

  • 1. Cost Utility of Switching From Trivalent to Quadrivalent Influenza Vaccine in Turkey.
    Amiche A, Tanriover MD, Bellier L, Ugur B, Akin L.
    Value Health Reg Issues; 2021 Sep; 25():15-22. PubMed ID: 33485248
    [Abstract] [Full Text] [Related]

  • 2. Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States.
    de Boer PT, Crépey P, Pitman RJ, Macabeo B, Chit A, Postma MJ.
    Value Health; 2016 Dec; 19(8):964-975. PubMed ID: 27987647
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model.
    Crépey P, Boiron L, Araujo RR, Lopez JG, Petitjean A, de Albuquerque Luna EJ.
    BMC Public Health; 2020 Sep 09; 20(1):1374. PubMed ID: 32907562
    [Abstract] [Full Text] [Related]

  • 8. Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis.
    Bianculli PM, Bellier L, Mangado IO, Pérez CG, Mieres G, Lazarov L, Petitjean A, Dibarboure H, Lopez JG.
    Hum Vaccin Immunother; 2022 Nov 30; 18(5):2050653. PubMed ID: 35344679
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain.
    García A, Ortiz de Lejarazu R, Reina J, Callejo D, Cuervo J, Morano Larragueta R.
    Hum Vaccin Immunother; 2016 Sep 30; 12(9):2269-77. PubMed ID: 27184622
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong.
    You JH, Ming WK, Chan PK.
    BMC Infect Dis; 2014 Nov 25; 14():618. PubMed ID: 25420713
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of quadrivalent versus trivalent influenza vaccine for elderly population in China.
    Jiang M, Li P, Wang W, Zhao M, Atif N, Zhu S, Fang Y.
    Vaccine; 2020 Jan 29; 38(5):1057-1064. PubMed ID: 31787414
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia.
    de Boer PT, Kelso JK, Halder N, Nguyen TP, Moyes J, Cohen C, Barr IG, Postma MJ, Milne GJ.
    Vaccine; 2018 Feb 08; 36(7):997-1007. PubMed ID: 29373192
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness analysis of switching from a trivalent to a quadrivalent inactivated influenza vaccine in the Peruvian immunisation programme.
    Bellier L, Petitjean A, Sarazu T, Tresierra J, Lopez JG.
    Vaccine; 2021 Jul 05; 39(30):4144-4152. PubMed ID: 34130885
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia.
    Jamotte A, Chong CF, Manton A, Macabeo B, Toumi M.
    BMC Public Health; 2016 Jul 22; 16():630. PubMed ID: 27449665
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis.
    You JH, Ming WK, Chan PK.
    Hum Vaccin Immunother; 2015 Jul 22; 11(3):564-71. PubMed ID: 25714506
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.